Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Acquisitions (2020 - 2023)

Historic Acquisitions for LifeStance Health (LFST) over the last 4 years, with Q1 2023 value amounting to $19.8 million.

  • LifeStance Health's Acquisitions fell 1361.95% to $19.8 million in Q1 2023 from the same period last year, while for Dec 2023 it was $19.8 million, marking a year-over-year decrease of 6707.97%. This contributed to the annual value of $19.8 million for FY2023, which is 6707.97% down from last year.
  • Per LifeStance Health's latest filing, its Acquisitions stood at $19.8 million for Q1 2023, which was down 1361.95% from $19.9 million recorded in Q4 2022.
  • LifeStance Health's Acquisitions' 5-year high stood at $40.9 million during Q4 2021, with a 5-year trough of $754000.0 in Q1 2021.
  • For the 4-year period, LifeStance Health's Acquisitions averaged around $19.3 million, with its median value being $19.9 million (2022).
  • Data for LifeStance Health's Acquisitions shows a peak YoY increase of 294310.34% (in 2022) and a maximum YoY decrease of 5129.75% (in 2022) over the last 5 years.
  • Over the past 4 years, LifeStance Health's Acquisitions (Quarter) stood at $30.1 million in 2020, then surged by 35.83% to $40.9 million in 2021, then tumbled by 51.3% to $19.9 million in 2022, then decreased by 0.46% to $19.8 million in 2023.
  • Its Acquisitions stands at $19.8 million for Q1 2023, versus $19.9 million for Q4 2022 and $5.2 million for Q3 2022.